Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0VRQ stock hub

LON/0VRQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0VRQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0VRQ

In the news

Latest news · LON/0VRQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-31.2

P25 n/aP50 n/aP75 n/a

ROIC-351.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0VRQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

USD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	393
Employees Change	-14%
Employees Change Percent	-3.44
Enterprise value	$2.7B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	CH0334081137
Last refreshed	2026-05-10
Market cap	$3.9B
Price	$55.56
Price currency	USD
Rev Per Employee	7,906.42x
Sic	2836
Symbol	lon/0VRQ
Website	https://www.crisprtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.09%
EV Earnings	-6.19x
EV/FCF	-8.78x
FCF yield	-7.83%
P/B ratio	2.82x
P/S ratio	1,249.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-362.5M
Net Income	$-430.6M
Pretax Margin	-13,774.56%
Profit Per Employee	$-1.1M
ROA	-14.06
Roa5y	-8.33
ROCE	-21.24
ROE	-31.21
Roe5y	-13.88
ROIC	-351.4
Roic5y	-91.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	60.79%
Cagr3y	-1.65%
Cagr5y	-13%
Revenue Growth	-89.11x
Revenue Growth Q	68.56x
Revenue Growth3 Y	-65.54x
Revenue Growth5 Y	30.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$2.1B
Cash	$1.8B
Current Assets	$1.8B
Current Liabilities	$100M
Debt	$596.5M
Debt Equity	$0.43
Debt FCF	$-1.96
Equity	$1.4B
Liabilities	$690.1M
Long Term Assets	$268.4M
Long Term Liabilities	$590.1M
Net Cash	$1.3B
Net Cash By Market Cap	$32.28
Net Cash Growth	1.11%
Net Debt Equity	$-0.91
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$14.26
WACC	11.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.96
Net Working Capital	$-84.1M
Quick ratio	17.92
Working Capital	$1.8B
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	60.74%
200-day SMA	56.29
3Y total return	-4.88%
50-day SMA	52.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-50.16%
All Time High	216.6
All Time High Change	-74.91%
All Time High Date	2021-01-15
All Time Low	30.04
All Time Low Change	80.86%
All Time Low Date	2025-04-07
ATR	3.28
Beta	1.74
Ch YTD	2.95
High	55.87
High52	78.47
High52 Date	2025-10-08
High52ch	-29.2%
Low	51.9
Low52	34.24
Low52 Date	2025-05-08
Low52ch	62.28%
Ma50ch	3.56%
Price vs 200-day SMA	-3.48%
RSI	55.69
RSI Monthly	51.43
RSI Weekly	52.36
Sharpe ratio	0.86x
Sortino ratio	1.48
Total Return	-8.27%
Tr YTD	2.95
Tr1m	9.54%
Tr1w	5.03%
Tr3m	12.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-416.6M
Operating margin	-13,408.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,018,164%
Net Borrowing	440,108,400
Shares Insiders	0.45%
Shares Institutions	80.26%
Shares Qo Q	0.82%
Shares Yo Y	8.27%
Short Ratio	11.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-355.8M
Average Volume	4,589.85x
Bv Per Share	14.26
CAPEX	$-917,854
Ch1m	9.54
Ch1w	5.03
Ch1y	60.74
Ch3m	12.4
Ch3y	-4.88
Ch5y	-50.16
Ch6m	0.7
Change	6.33%
Change From Open	5.97
Close	52.25
Days Gap	0.34
Depreciation Amortization	13,982,243.9
Dollar Volume	223,351.2
Earnings Date	2026-05-11
EBIT	$-416.6M
EBITDA	$-402.2M
EPS	$-4.66
F Score	2
FCF	$-303.8M
FCF EV Yield	-11.39x
Financing CF	762,868,163
Fiscal Year End	December
Founded	2,013
Income Tax	$2.5M
Investing CF	-320,183,253
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2026-03-31
Ma150	55.81
Ma150ch	-2.64%
Ma20	54.3
Ma20ch	0.05%
Net CF	139,806,833
Next Earnings Date	2026-05-11
Open	52.43
Position In Range	92.19
Ppne	176,663,912.8
Price Date	2026-05-08
Ptbv Ratio	2.82
Relative Volume	0.88x
Revenue	3,107,222x
SBC By Revenue	1,672.22x
Share Based Comp	51,959,453
Tax By Revenue	81.99x
Tr6m	0.7%
Volume	4,020
Z Score	2.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0VRQ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0VRQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0VRQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.3%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0VRQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.7

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

1.74

More volatile than the market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0VRQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0VRQ stock rating?

lon/0VRQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0VRQ analysis?

The full report lives at /stocks/lon/0VRQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0VRQ?

The latest report frames lon/0VRQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0VRQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.